|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2002-12-24
|
|
pubmed:abstractText |
Stroke is a frequent cause of epileptic seizures (ES) in adults. The authors evaluated the long-term efficacy and tolerability of gabapentin (900 to 1,800 mg/day) in 71 patients with a first poststroke late ES during a mean follow-up time of 30 months. ES recurred in 18.3% of the patients and side effects were noted in 27 cases (38%), but only two (2.8%) required discontinuation or early withdrawal. Gabapentin monotherapy was useful and safe for late poststroke ES.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0028-3878
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
24
|
|
pubmed:volume |
59
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1991-3
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12499501-Acetic Acids,
pubmed-meshheading:12499501-Aged,
pubmed-meshheading:12499501-Amines,
pubmed-meshheading:12499501-Anticonvulsants,
pubmed-meshheading:12499501-Cyclohexanecarboxylic Acids,
pubmed-meshheading:12499501-Dose-Response Relationship, Drug,
pubmed-meshheading:12499501-Female,
pubmed-meshheading:12499501-Follow-Up Studies,
pubmed-meshheading:12499501-Humans,
pubmed-meshheading:12499501-Male,
pubmed-meshheading:12499501-Middle Aged,
pubmed-meshheading:12499501-Prospective Studies,
pubmed-meshheading:12499501-Recurrence,
pubmed-meshheading:12499501-Seizures,
pubmed-meshheading:12499501-Stroke,
pubmed-meshheading:12499501-gamma-Aminobutyric Acid
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Gabapentin in late-onset poststroke seizures.
|
|
pubmed:affiliation |
Cerebrovascular Unit, Department of Neurology, Hospital Vall d'Hebron, Barcelona, Spain. alsa@hg.vhebron.es
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
